Caliber Imaging & Diagnostics (LCDX) Stock Price, News & Analysis

Company Overview

Caliber Imaging & Diagnostics, Inc. develops medical imaging technologies designed to support the visualization and evaluation of biological tissue. The company is best known for its VivaScope line of confocal microscopy systems, which provide high-resolution images of tissue at or near the cellular level without requiring conventional histological processing.

The company’s products have been used primarily in dermatology and skin-cancer evaluation, where physicians and researchers can use noninvasive or minimally invasive imaging to examine suspicious lesions and other skin conditions. Its technology has also been applied in clinical research and pathology-related settings, including the assessment of tissue samples.

Caliber Imaging & Diagnostics was formerly known as Lucid, Inc. and has marketed its imaging systems to medical institutions, physicians, researchers, and other healthcare professionals. Publicly available information about the company’s current operations, geographic reach, and leadership is limited.

Key Stats

• Today's Range: $0.0001 to $0.0001
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.05
• Volume: 100 shs
• Average Volume: 6,842 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:LCDX
• CIK: N/A
• Web: www.caliberid.com
• Phone: 585-239-9800
• Fax: N/A
• Employees: 28
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A